ABVC BIOPHARMA, INC. Annual Operating Income (Loss) in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Abvc Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
  • Abvc Biopharma, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$2.29M, a 167% decline year-over-year.
  • Abvc Biopharma, Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$3.99M, a 37.2% increase year-over-year.
  • Abvc Biopharma, Inc. annual Operating Income (Loss) for 2024 was -$4.71M, a 30.5% increase from 2023.
  • Abvc Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$6.77M, a 55.2% increase from 2022.
  • Abvc Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$15.1M, a 29.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$4.71M +$2.06M +30.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 -$6.77M +$8.35M +55.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 -$15.1M -$3.41M -29.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$11.7M -$3.2M -37.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$8.51M -$5.05M -146% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$3.46M -$674K -24.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 -$2.78M +$1.35M +32.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-05-15
2017 -$4.14M +$6.86M +62.4% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-15
2016 -$11M Oct 1, 2015 Sep 30, 2016 10-KT 2018-04-13
2013 -$177K +$966K +84.5% Oct 1, 2012 Sep 30, 2013 10-K 2015-04-16
2012 -$1.14M +$745K +39.5% Oct 1, 2011 Sep 30, 2012 10-K 2015-04-16
2011 -$1.89M +$1.61K +0.09% Oct 1, 2010 Sep 30, 2011 10-K 2015-04-15
2010 -$1.89M Oct 1, 2009 Sep 30, 2010 10-K/A 2011-12-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.